Femoston 1mg/1mg/10mg Tablet is a combination hormone replacement therapy containing Estradiol (1mg + 1mg) and Dydrogesterone (10mg), primarily used to manage symptoms associated with menopause such as hot flashes, night sweats, vaginal dryness, and osteoporosis prevention. Estradiol, a form of estrogen, helps restore declining estrogen levels in postmenopausal women, alleviating vasomotor symptoms and improving bone density. Dydrogesterone, a synthetic progestogen, complements estradiol by protecting the endometrium from hyperplasia that can result from unopposed estrogen therapy, reducing the risk of endometrial cancer. This medication is typically prescribed for women who have not undergone hysterectomy and require both estrogen and progestogen supplementation. Femoston is administered orally, usually once daily, with the dosage and duration tailored to individual needs and medical history. It is important to use this therapy under medical supervision due to potential risks such as thromboembolic events, cardiovascular issues, and breast cancer. Patients should inform their healthcare provider of any history of hormone-sensitive cancers, liver disease, or blood clots before starting treatment. Regular follow-up is essential to monitor therapy effectiveness and side effects. Femoston offers effective relief from menopausal symptoms while supporting overall hormonal balance.